Home/Filings/4/0000874015-25-000278
4//SEC Filing

Birchler Brian 4

Accession 0000874015-25-000278

CIK 0000874015other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 5:13 PM ET

Size

5.3 KB

Accession

0000874015-25-000278

Insider Transaction Report

Form 4
Period: 2025-11-06
Birchler Brian
EVP, Corp and Development Ops
Transactions
  • Sale

    Common Stock

    2025-11-06$76.17/sh8,000$609,37948,826 total
Footnotes (2)
  • [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 12, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.00 to $76.32 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.

Issuer

IONIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeother

Related Parties

1
  • filerCIK 0001970151

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 5:13 PM ET
Size
5.3 KB